#current partners

Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza

Lebanon, NH – January 9, 2015 – Adimab, LLC, the technology leader in the discovery of monoclonal and bispecific antibodies, today announced independent discovery collaborations with Acceleron Pharma, Inc., Oncothyreon, Inc., Surface Oncology, Inc. and Potenza Therapeutics, Inc. All four collaborations are structured as funded discovery programs in which Adimab will discover and optimize…